TREM2 Impedes Recovery After Spinal Cord Injury by Regulating Microglial Lysosomal Membrane Permeabilization-Mediated

Tianlun Zhao1,2, Jiawei Di1,2, Yu Kang1,2

  • 1Department of Spine Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Cell Proliferation
|May 5, 2025
PubMed

Insights

TREM2 deficiency enhances microglial autophagy and lysosomal function after spinal cord injury. This promotes functional recovery and offers a potential gene therapy strategy for central nervous system disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are key immune responders in the central nervous system (CNS).
  • TREM2 is highly expressed in microglia and influences their function.
  • The role of TREM2 in spinal cord injury (SCI) remains unexplored.

Purpose of the Study:

  • Investigate the mechanism of TREM2 in SCI.
  • Determine TREM2's role in microglial regulation of neuroinflammation.
  • Explore therapeutic potential for CNS disorders.

Main Methods:

  • Single-cell sequencing in wild-type and Trem2 knockout mice pre- and post-SCI.
  • Analysis of lysosomal and autophagy pathways.
  • In vitro and in vivo experiments assessing Trem2 silencing effects on autophagy and SCI recovery.
  • Functional and histological assessments including gait analysis and tissue staining.

Main Results:

  • TREM2 deficiency activates lysosome, autophagy, and membrane-related pathways in microglia post-SCI.
  • TREM2 knockout reduces TFEB nuclear translocation by decreasing Syk phosphorylation.
  • Silencing Trem2 promotes autophagy by repairing lysosomal membrane permeabilization.
  • Increased autophagy rescues microglia and improves functional and histological recovery after SCI.

Conclusions:

  • Microglial lysosomal autophagy is regulated in a TREM2-dependent lysosomal membrane permeabilization (LMP) manner.
  • Targeting microglial autophagy presents a promising therapeutic strategy for SCI.
  • This study provides a basis for gene therapy approaches in lysosome-related CNS disorders.